Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation
TRANSPLANTATION PROCEEDINGS（1999）
摘要
Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要